Genetic variants in the major histocompatibility complex class i and class II genes are associated with diisocyanate-induced asthma

Journal of Occupational and Environmental Medicine

Volumn 56, Issue 4, 2014, Pages 382-387

  Yucesoy, Berran ^a,c   Johnson, Victor J ^b   Lummus, Zana L ^c   Kashon, Michael L ^a   Rao, Marepalli ^d   Bannerman Thompson, Hansen ^d   Frye, Bonnie ^a   Wang, Wei ^a   Gautrin, Denyse ^e   Cartier, André ^e   Boulet, Louis Philippe ^f   Sastre, Joaquin ^g   Quirce, Santiago ^h   Tarlo, Susan M ⁱ   Germolec, Dori R ^j   Luster, Michael I ^k   Bernstein, David I ^c  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b BRT Burleson Research Technologies   (United States)

^c Division of Immunology Allergy and Rheumatology   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^h INSTITUTO DE SALUD CARLOS III   (Spain)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^k WEST VIRGINIA UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIISOCYANATE; ISOCYANATE; UNCLASSIFIED DRUG; ISOCYANIC ACID DERIVATIVE;

ADULT; ARTICLE; ASTHMA; DIISOCYANATE INDUCED ASTHMA; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HLA B GENE; HLA DOA GENE; HLA DPB1 GENE; HLA DQA2 GENE; HLA E GENE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 GENE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 GENE; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; CHEMICALLY INDUCED; CLINICAL TRIAL; GENETICS; GENOTYPE; MULTICENTER STUDY; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; RISK; TOXICITY;

ADULT; ASTHMA; FEMALE; GENES, MHC CLASS I; GENES, MHC CLASS II; GENETIC VARIATION; GENOTYPE; HUMANS; ISOCYANATES; MALE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84898456741     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000138     Document Type: Article

References (42)

1. Wisnewski AV, Redlich CA. Recent developments in diisocyanate asthma. Curr Opin Allergy Clin Immunol. 2001;1:169-175.
2. Redlich CA, Karol MH. Diisocyanate asthma: clinical aspects and im-munopathogenesis. Int Immunopharmacol. 2002;2:213-224.
3. Bernstein JA. Overview of diisocyanate occupational asthma. Toxicology. 1996;111:181-189.
4. Park HS, Park JN, Kim JW, Kim SK. Clinical and immunological evaluation of isocyanate-exposed workers. J Korean Med Sci. 1992;7:122-127.
5. Lincoln MR, Montpetit A, Cader MZ, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet. 2005;37:1108-1112.
6. Mapp CE, Beghe B, Balboni A, et al. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin Exp Allergy. 2000;30:651-656.
7. Bernstein DI. Genetics of occupational asthma. Curr Opin Allergy Clin Immunol. 2011;11:86-89.
8. Mapp CE, Balboni A, Baricordi R, Fabbri LM. Human leukocyte antigen associations in occupational asthma induced by isocyanates. Am J Respir Crit Care Med. 1997;156:S139-S143.
9. Young RP, Barker RD, Pile KD, Cookson WO, Taylor AJ. The association of HLA-DR3 with specific IgE to inhaled acid anhydrides. Am J Respir Crit Care Med. 1995;151:219-221.
10. Newman Taylor AJ, Cullinan P, Lympany PA, Harris JM, Dowdeswell RJ, du Bois RM. Interaction of HLA phenotype and exposure intensity in sensitiza-tion to complex platinum salts. Am J Respir Crit Care Med. 1999;160:435-438.
11. Bignon JS, Aron Y, Ju LY, et al. HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med. 1994;149:71-75.
12. Choi JH, Lee KW, Kim CW, et al. The HLA DRB1*1501-DQB1*0602- DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma. Int Arch Allergy Immunol. 2009;150:156-163.
13. Kim SH, Oh HB, Lee KW, et al. HLA DRB1*15-DPB1*05 haplotype: a susceptible gene marker for isocyanate-induced occupational asthma? Allergy. 2006;61:891-894.
14. Hur GY, Lee KW, Lee HY, et al. HLA class II allele and IgG sensitization to methylene diisocyanate in exposed workers. Ann Allergy Asthma Immunol. 2009;103:174-175
15. Consortium-MHC. Complete sequence and gene map of a human major his-tocompatibility complex. Nature. 1999;401:921-923.
16. Sastre J, Fernandez-Nieto M, Novalbos A, De Las Heras M, Cuesta J, Quirce S. Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge. Chest. 2003;123:1276-1279.
17. Malo JL, Ghezzo H, Elie R. Occupational asthma caused by isocyanates: patterns of asthmatic reactions to increasing day-to-day doses. Am J Respir Crit Care Med. 1999;159:1879-1883.
18. Campo P, Wisnewski AV, Lummus Z, et al. Diisocyanate conjugate and immunoassay characteristics influence detection of specific antibodies in HDI-exposed workers. Clin Exp Allergy. 2007;37:1095-1102.
19. Boyle AP, Hong EL, Hariharan M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22:1790-1797.
20. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008;24:2938-2939
21. International HapMap 3 Consortium Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467:52-58.
22. Park HS, Kim HY, Nahm DH, Son JW, Kim YY. Specific IgG, butnot specific IgE, antibodies to toluene diisocyanate-human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results. J Allergy Clin Immunol. 1999;104:847-851.
23. Bentley AM, Maestrelli P, Saetta M, et al. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol. 1992;89:821-829.
24. Cartier A, Grammer L, Malo JL, et al. Specific serum antibodies against isocyanates-association with occupational asthma. J Allergy Clin Immun. 1989;84:507-514.
25. Lummus ZL, Wisnewski AV, Bernstein DI. Pathogenesis and disease mechanisms of occupational asthma. Immunol Allergy Clin N Am.2011;31:699-716, vi.
26. Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol. 2011;11:823-836.
27. Beghe B, Padoan M, Moss CT, et al. Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. Allergy. 2004;59:61-64.
28. Morris MJ, Vaughan H, Lane DJ, Morris PJ. HLA in asthma. Monogr Allergy. 1977;11:30-34.
29. Wang WX, Yang SZ, Chui XW, Zhang HL. Association of HLA-Bw61 with asthma in the Chinese. Tissue Antigens. 1988;32:215-217.
30. Sjostedt L, Willers S, Orbaek P. Human leukocyte antigens in occupational allergy: a possible protective effect of HLA-B16 in laboratory animal allergy. Am J Ind Med. 1996;30:415-420.
31. Noguchi E, Sakamoto H, Hirota T, et al. Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations. PLoS Genet. 2011;7:e1002170.
32. Choi JH, Lee KW, Oh HB, et al. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. J Allergy Clin Immunol. 2004;113:562-564.
33. Caraballo L, Marrugo J, Jimenez S, Angelini G, Ferrara GB. Frequency of DPB1*0401 is significantly decreased in patients with allergic asthma in a mulatto population. Hum Immunol. 1991;32:157-161.
34. Denzin LK, Fallas JL, Prendes M, Yi W. Right place, right time, right peptide: DO keeps DM focused. Immunol Rev. 2005;207:279-292.
35. Reynolds RJ, Kelley JM, Hughes LB, Yi N, Bridges SL Jr. Genetic association of htSNPs across the major histocompatibility complex with rheumatoid arthritis in an African-American population. Genes Immun. 2010;11:94-97.
36. Marsh DG, Meyers DA, Bias WB. The epidemiology and genetics of atopic allergy. N Engl J Med. 1981;305:1551-1559.
37. Balboni A, Baricordi OR, Fabbri LM, Gandini E, Ciaccia A, Mapp CE. Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57. Eur Respir J. 1996;9:207-210.
38. Rihs HP, Barbalho-Krolls T, Huber H, Baur X. No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma. Am J Ind Med. 1997;32:522-527.
39. Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2011;363:1211-1221.
40. Li X, Howard TD, Zheng SL, et al. Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. J Allergy Clin Immunol. 2010;125:328-335 e311.
41. Malo JL, Ghezzo H, D'Aquino C, L'Archeveque J, Cartier A, Chan-Yeung M. Natural history of occupational asthma: relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. J Allergy Clin Immunol. 1992;90:937-944.
42. Martin AM, Nolan D, Gaudieri S, et al. Predisposition to abacavir hypersensi-tivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc Natl Acad Sci USA. 2004;101:4180-4185.